Evidence map›Paper›PMID 40973335›Full record

ArticleJACC. Case reports2025

The Intersection of a Rare Mass and Dual Primary Malignancies: A 73-Year-Old Male Patient's Cardiac Conundrum.

Santiago Luna-Alcala, Marco Antonio Peña-Cabral, Magali Herrera-Gomar, Javier Sánchez-Zavala, Rita Dorantes Heredia, Octavio González-Chon

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Santiago Luna-AlcalaInternal Medicine Department, Medica Sur Clinic and Foundation, Mexico City, Mexico.
Marco Antonio Peña-CabralIntermediate Care Unit Department, Medica Sur Clinic and Foundation, Mexico City, Mexico. Electronic address: marcoapec@gmail.com.
Magali Herrera-GomarIntermediate Care Unit Department, Medica Sur Clinic and Foundation, Mexico City, Mexico.
Javier Sánchez-ZavalaIntermediate Care Unit Department, Medica Sur Clinic and Foundation, Mexico City, Mexico.
Rita Dorantes HerediaPathology Department, Medica Sur Clinic and Foundation, Mexico City, Mexico.
Octavio González-ChonIntermediate Care Unit Department, Medica Sur Clinic and Foundation, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntimal sarcoma (IS) is a rare malignant tumor originating from the tunica intima of large blood vessels, mainly in the pulmonary circulation. Prevalence is extremely low (0.001%), with IS of the pulmonary vein even rarer than IS of the pulmonary artery (0.001%-0.003%). CASE SUMMARY: A 73-year-old man with malignant peripheral nerve sheath tumor and high-grade urothelial carcinoma was diagnosed with grade 3 pulmonary vein IS during evaluation of probable acute decompensated heart failure. Echocardiography showed a hyperechoic mass extending from the pulmonary vein into the left atrium and protruding into the left ventricle. The patient underwent surgical resection. DISCUSSION: Despite invasive interventions, aggressive IS often recurs, making regular imaging follow-up essential for early detection of metastasis and highlighting the need for further research into effective treatment strategies. TAKE-HOME MESSAGE: This case highlights the importance of including pulmonary vein IS in the differential diagnosis of left atrial masses and the value of multimodality imaging for timely detection and surgical planning.

Indexed as

cardiac tumorsechocardiographyhistopathologyimmunohistochemicalintimal sarcomamalignancy

Identifiers

PMID40973335
PMCPMC12478517

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.